BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Chronic hepatitis B
1
Risk factors and predictive model for hepatitis B virus deoxyribonucleic acid elevation in mid-to-late pregnancy with low viremia
10/21/2026 2:09:39 AM | Browse: 15 | Download: 28
2
Pegylated interferon α-2b add-on to nucleos(t)ide analogues reduces hepatocellular carcinoma and decompensation in advanced fibrotic chronic hepatitis B
10/15/2026 5:45:55 AM | Browse: 36 | Download: 97
3
From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B
9/17/2026 5:48:20 AM | Browse: 34 | Download: 71
4
Biological interpretation of baseline hepatitis B surface antigen and cirrhosis in determining interferon treatment duration
9/7/2026 2:26:33 AM | Browse: 52 | Download: 90
5
Predictive model to identify patients requiring extended interferon therapy in chronic hepatitis B
9/1/2026 6:22:40 AM | Browse: 34 | Download: 75
6
Routine laboratory model for identifying significant fibrosis in chronic hepatitis B
6/26/2026 9:50:21 AM | Browse: 60 | Download: 281
7
Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines
6/26/2026 9:50:19 AM | Browse: 45 | Download: 219
8
Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B
6/18/2026 7:52:55 AM | Browse: 60 | Download: 258
9
Bone and renal safety of initial antiviral therapy using tenofovir alafenamide fumarate or entecavir for chronic hepatitis B
5/29/2026 7:26:46 AM | Browse: 59 | Download: 355
10
Beyond fibrosis: The imperative for dual steatosis and fibrosis assessment in chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease co-pathology
5/26/2026 3:52:09 AM | Browse: 45 | Download: 212
11
Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study
5/26/2026 3:52:08 AM | Browse: 68 | Download: 308
12
Why does hepatitis B remain underprioritized? A view through lived experience
4/23/2026 11:05:50 AM | Browse: 104 | Download: 337
13
Baseline hepatitis B surface antigen and cirrhosis predict extended interferon therapy in chronic hepatitis B: A retrospective study
3/19/2026 7:07:29 AM | Browse: 105 | Download: 413
14
Predictive tool for evident histological liver injury in chronic hepatitis B patients: Development and validation
2/12/2026 11:20:21 AM | Browse: 144 | Download: 584
15
Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B
2/12/2026 11:20:19 AM | Browse: 144 | Download: 587
16
Adherence to antiviral treatment among people living with chronic hepatitis B: A global survey
12/25/2025 9:13:55 AM | Browse: 122 | Download: 533
17
Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B
11/28/2025 3:10:38 AM | Browse: 310 | Download: 634
18
Meta-analysis of factors associated with the incidence of comorbid depression and anxiety in patients with chronic hepatitis B
11/4/2025 2:41:47 AM | Browse: 324 | Download: 775
19
Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice
10/27/2025 10:57:50 AM | Browse: 441 | Download: 617
20
Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B
10/24/2025 7:36:34 AM | Browse: 364 | Download: 560
21
Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B
10/24/2025 7:36:26 AM | Browse: 221 | Download: 469
22
Psychological distress and treatment adherence-challenges of patients with chronic hepatitis B: Risk factors and integrated nursing strategies
9/26/2025 8:18:47 AM | Browse: 574 | Download: 583
23
Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report
9/25/2025 11:24:05 AM | Browse: 191 | Download: 595
24
Anti-hepatitis B virus effects of traditional Chinese medicine: Learning from clinical trials in the past twenty years
9/25/2025 11:24:00 AM | Browse: 433 | Download: 553
25
Chronic hepatitis B: Is it time for expanded antiviral treatment?
9/25/2025 9:22:03 AM | Browse: 288 | Download: 436
26
Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics
7/25/2025 12:09:41 PM | Browse: 315 | Download: 720
27
Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis
7/15/2025 8:26:32 AM | Browse: 323 | Download: 1059
28
Rate of abnormal renal function index and related risk factors in patients with chronic hepatitis B
7/4/2025 9:23:52 AM | Browse: 227 | Download: 987
29
Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B
5/27/2025 7:04:48 AM | Browse: 384 | Download: 1194
30
Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease
5/27/2025 7:04:47 AM | Browse: 337 | Download: 977
31
Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients
3/13/2025 10:11:05 AM | Browse: 292 | Download: 955
32
Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment
2/26/2025 4:21:35 AM | Browse: 290 | Download: 695
33
CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment
12/20/2024 3:53:46 AM | Browse: 115 | Download: 572
34
Current status of drug therapy for chronic hepatitis B
12/18/2024 7:36:02 AM | Browse: 345 | Download: 910
35
Revolutionizing the understanding of liver disease: Metabolism, function and future
11/29/2024 2:50:19 PM | Browse: 397 | Download: 1108
36
Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus
11/29/2024 2:50:18 PM | Browse: 392 | Download: 1381
37
Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens
11/12/2024 6:08:07 AM | Browse: 193 | Download: 1235
38
Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action
11/6/2024 9:50:59 AM | Browse: 324 | Download: 1065
39
Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway
10/31/2024 10:42:49 AM | Browse: 368 | Download: 961
40
Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return
10/21/2024 7:03:25 AM | Browse: 366 | Download: 862
41
Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered
7/26/2024 10:33:30 AM | Browse: 399 | Download: 1216
42
Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
7/26/2024 10:33:30 AM | Browse: 455 | Download: 1759
43
Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients
7/9/2024 2:00:35 PM | Browse: 314 | Download: 835
44
Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors
6/25/2024 10:41:21 AM | Browse: 426 | Download: 842
45
Hepatitis B cure: Current situation and prospects
6/20/2024 3:42:22 AM | Browse: 380 | Download: 1066
46
Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
6/20/2024 3:42:22 AM | Browse: 247 | Download: 1420
47
Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy
3/27/2024 1:28:19 PM | Browse: 414 | Download: 1529
48
Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study
3/11/2024 2:44:49 PM | Browse: 530 | Download: 1556
49
Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis
3/6/2024 6:10:52 AM | Browse: 504 | Download: 1392
50
Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study
2/4/2024 10:57:42 AM | Browse: 570 | Download: 1848
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.